Alcoholic liver disease

Published on 08/04/2015 by admin

Filed under Gastroenterology and Hepatology

Last modified 08/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2246 times

Chapter 40 ALCOHOLIC LIVER DISEASE

KEY POINTS

• Alcohol is one of the most common causes of liver disease—alcoholic liver disease (ALD).
• The clinical and pathological spectrum of ALD includes fatty liver, hepatitis and cirrhosis, which may lead to complications including portal hypertension, liver failure and hepatocellular carcinoma.
• Recent and past alcohol consumption should be assessed in all cases of liver disease.
• The most useful laboratory marker for alcohol abuse is gammaglutamyltransferase (GGT), but this is only moderately sensitive.
• Hepatitis C virus (HCV) infection in ALD is associated with more severe liver disease.
• Liver biopsy is a very useful diagnostic tool, but is infrequently required.
• Abstinence from alcohol is the major factor that influences survival.
• Severe alcoholic hepatitis is uncommon with a mortality of 1 in 3 in the first 30 days.
• Corticosteroids and pentoxifylline are effective for short-term treatment of severe alcoholic hepatitis.
• Liver transplantation may be considered in highly selected cases where liver disease progresses despite sustained abstinence.

Alcohol remains one of the most common causes of liver disease and contributes to 1000 deaths and 64,000 hospital admissions per year in Australia. National per capita alcohol consumption correlates with mortality from alcoholic liver disease (ALD), has fallen from a peak in 1985 but has been relatively static for the last decade.

PATHOLOGY AND CLINICAL PRESENTATION

Symptoms and signs are not reliable indicators of the presence or severity of ALD. There may be no symptoms even in the presence of cirrhosis. In other cases, clinical features do allow a confident diagnosis. The clinical and pathological spectrum of alcoholic liver disease includes fatty liver, hepatitis and cirrhosis, but these commonly coexist.

Alcoholic fatty liver

Alcoholic fatty liver results from accumulation of fat droplets within hepatocytes (steatosis) without inflammation or fibrosis. It may commence after a few days of heavy drinking and manifests as anorexia, nausea and right upper quadrant discomfort. The liver is enlarged, firm and may be tender. There are typically no other signs.

Alcoholic hepatitis

Alcoholic hepatitis is defined pathologically by polymorphonuclear infiltration with hepatocyte injury (ballooning necrosis and apoptosis), accumulation of Mallory’s hyaline (derived from intermediate filaments) and variable hepatic fibrosis. It presents with anorexia, nausea and abdominal pain, with jaundice, bruising and encephalopathy in association with alcohol abuse. Hepatomegaly may be marked and associated with tenderness, splenomegaly, signs of liver failure and ascites. Systemic disturbances include fever and neutrophilic leucocytosis. The gamma-glutamyltransferase (GGT) is the predominant abnormality. The AST generally exceeds the ALT, but both are only moderately raised. Values for aspartate aminotransferase (AST) or alanine aminotransferase (ALT) above 500 U/L suggest another disorder that may coexist with ALD, most often viral hepatitis or paracetamol (acetaminophen) toxicity.

Mild cases are common and typically manifest with abnormal serum biochemistry, and hepatomegaly. Severe alcoholic hepatitis is relatively rare and carries a short-term mortality of approximately 50%. The severity of alcoholic hepatitis can be assessed using a number of simple quantitative indices (Maddrey score, MELD Score, Combined Clinical and Laboratory Index). Of these, the Maddrey Discriminant Function (MDF) is the simplest (Table 40.1).

TABLE 40.1 Using the Maddrey score to assess the severity of alcoholic hepatitis

Maddrey score = 4.6 × (prolongation of prothrombin time above control in seconds) + bilirubin (μmol/L)/17
Interpretation: Short-term (30 day) mortality is related to the Maddrey score
Maddrey score >32 is associated with mortality of 30%–50%
Maddrey score <32 is associated with minimal mortality
Example: Patient prothrombin time 16 s, bilirubin 150 μmol/L, laboratory control prothrombin time 12 s
Maddrey score = 4.6 × (16 – 12) + 150/17 = 26. This indicates a low likelihood of mortality during the current admission

Alcoholic cirrhosis

Alcoholic cirrhosis may present with fatigue, anorexia, nausea, malaise or weight loss but typically presents with complications such as portal hypertension leading to variceal bleeding and/or ascites, liver failure and hepatocellular carcinoma. Alcoholic cirrhosis is a recognised risk factor for hepatocellular carcinoma but it is not clear that there is an association between alcohol abuse and hepatocellular carcinoma in the absence of cirrhosis.

Physical examination may be normal in compensated cirrhosis. Peripheral signs include spider naevi, palmar erythema and Dupuytren’s contracture (a sign of alcohol use but not cirrhosis). Among hospitalised patients, hepatomegaly is the most common finding. Jaundice, ascites and encephalopathy are found in about half and alcohol withdrawal is evident in 29% of patients.

Pathogenesis

The risk of cirrhosis correlates with daily average consumption above a threshold of 20 g per day for women and 40 g per day for men. ALD is a multi-step chronic disease process (Figure 40.1).

image

FIGURE 40.1 Overview of the pathogenesis of alcoholic hepatitis.

ADH = alcohol dehydrogenase; PDGF = platelet -derived growth factor; TGF-β = transforming growth factor beta; TLR4 = toll-like receptor 4; TNF-α = tumor necrosis factor alpha.

The risk of liver disease is related to the amount of alcohol consumed, but female gender, other undefined genetic factors, chronic viral hepatitis, hepatotoxins, obesity and other nutritional impairment all accelerate the disease process. Hepatitis C is more common in alcoholics than in the general community and when the two are combined, liver disease progresses more rapidly.

Excessive drinkers are at increased risk of some types of drug-induced liver injury. For example, paracetamol in apparently therapeutic doses has led to acute liver failure in alcoholics and methotrexate accelerates hepatic fibrosis in heavy drinkers.

DETECTION OF ALCOHOL ABUSE

A quantitative alcohol history should be recorded for all patients. Average daily consumption is expressed in grams of alcohol or standard drinks (each containing 10 g ethanol). Consumption is frequently underreported. In some cases, alcohol abuse may be recognised via other typical medical or psychosocial problems such as depression, neurological toxicity, abdominal pain, relationship difficulties, poor work performance, trauma and violence.

Several brief questionnaires have been validated for the detection of alcohol abuse (Table 40.2). If a screening test is positive, more detailed assessment is indicated.

TABLE 40.2 Screening questions for excessive alcohol consumption

A positive response on screening indicates the need for further assesssment

a. AUDIT (original version has 10 questions, but question 3 on its own is very useful)

How often do you have six or more drinks on one occasion? (positive response is monthly or more)

b. The CAGE screening questions: two or more positive responses suggest alcohol dependence

C – Have you ever felt the need to cut down your drinking?
A – Have you ever felt annoyed by criticism of your drinking?
G – Have you ever felt guilty about your drinking?
E – Have you ever taken a drink (eye-opener) first thing in the morning?

Buy Membership for Gastroenterology and Hepatology Category to continue reading. Learn more here

Related posts:

Ascites Acute abdominal pain Chronic pancreatitis Suspected iron overload or high serum ferritin Medical problems after liver transplantation The hepatitis B-positive patient